AS

Arvindkumar Singh

Active Director Director DIN 07295588
DIN 07295588 First appointment Oct 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2015
Shareholding value •••• Premium profile

About Arvindkumar Singh

Data last updated:

Arvindkumar Singh is a Director at Yajas Pharmaceuticals Private Limited (since 2015). The company operates in Chemicals. Yajas Pharmaceuticals Private Limited reported revenue of ₹7.5 Lakh (FY 2024).

DIN 07295588
Primary Designation Director
Industry Chemicals
First Appointment 23 Oct 2015
Oldest Company Age 11 yrs
Largest company Yajas Pharmaceuticals Private Limited · ₹7.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Oct 20152015₹7.5 Lakh (FY 2024)Active

Board colleagues of Arvindkumar Singh

Directorship timeline

Open interactive timeline →
Yajas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arvindkumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arvindkumar Singh

Arvindkumar Singh currently holds 1 directorship: Yajas Pharmaceuticals Private Limited (Director, since 23 Oct 2015, revenue ₹7.5 Lakh (FY 2024)).

Arvindkumar Singh was first appointed on 23 Oct 2015 as Director at Yajas Pharmaceuticals Private Limited.

The current boards of Arvindkumar Singh's companies include Abhishek Lawu Rane (Yajas Pharmaceuticals Private Limited), Durgesh Manglaprasad Mishra (Yajas Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available